SrasV1, PubMed, Checkpoint, bibRecord, 001824

Oral immunization of mice with recombinant Lactococcus lactis expressing porcine transmissible gastroenteritis virus spike glycoprotein.

Identifieur interne : 001824 ( PubMed/Checkpoint ); précédent : 001823; suivant : 001825

Oral immunization of mice with recombinant Lactococcus lactis expressing porcine transmissible gastroenteritis virus spike glycoprotein.

Auteurs : Lijie Tang [République populaire de Chine] ; Yijing Li

Source :

Virus genes [ 1572-994X ] ; 2009.

RBID : pubmed:19629668

Descripteurs français

English descriptors

KwdEn :
- Administration, Oral, Animals, Antibodies, Neutralizing (immunology), Antibodies, Viral (immunology), Drug Carriers, Enzyme-Linked Immunosorbent Assay, Genetic Vectors, Intestinal Mucosa (immunology), Lactococcus lactis (genetics), Membrane Glycoproteins (genetics), Membrane Glycoproteins (immunology), Mice, Mice, Inbred BALB C, Neutralization Tests, Recombinant Proteins (genetics), Recombinant Proteins (immunology), Serum (immunology), Spike Glycoprotein, Coronavirus, Transmissible gastroenteritis virus (genetics), Transmissible gastroenteritis virus (immunology), Vaccines, Synthetic (genetics), Vaccines, Synthetic (immunology), Viral Envelope Proteins (genetics), Viral Envelope Proteins (immunology), Viral Vaccines (administration & dosage), Viral Vaccines (genetics), Viral Vaccines (immunology).
MESH :
- chemical , administration & dosage : Viral Vaccines.
- chemical , genetics : Membrane Glycoproteins, Recombinant Proteins, Vaccines, Synthetic, Viral Envelope Proteins, Viral Vaccines.
- chemical , immunology : Antibodies, Neutralizing, Antibodies, Viral, Membrane Glycoproteins, Recombinant Proteins, Vaccines, Synthetic, Viral Envelope Proteins, Viral Vaccines.
- genetics : Lactococcus lactis, Transmissible gastroenteritis virus.
- immunology : Intestinal Mucosa, Serum, Transmissible gastroenteritis virus.
- Administration, Oral, Animals, Drug Carriers, Enzyme-Linked Immunosorbent Assay, Genetic Vectors, Mice, Mice, Inbred BALB C, Neutralization Tests, Spike Glycoprotein, Coronavirus.

Abstract

Lactococcus lactis NZ9000 was selected as an antigen delivery vehicle for mucosal immunization against porcine transmissible gastroenteritis virus (TGEV) infection. An approximately 70 kDa fragment of the N-terminal globular domain of the spike (S) protein (SN protein) from the coronavirus TGEV was used as the transmissible gastroenteritis virus antigen model. Recombinant L. lactis, expressing the SN protein, was constructed with the pNZ8112 plasmid. Expression and localization of the transcribed SN protein from the recombinant LNZ9000- rTGEV-SN were detected via SDS-PAGE, Western blot, and immunofluorescence. BALB/c mice, orally immunized with LNZ9000-rTGEV-SN, produced local mucosal immune responses against TGEV. The induced antibodies demonstrated neutralizing effects on TGEV infection. These data indicated that the recombinant L. lactis could be a valuable tool in the development of future vaccines against TGEV.

DOI: 10.1007/s11262-009-0390-x
PubMed: 19629668

Affiliations:

République populaire de Chine

Links toward previous steps (curation, corpus...)

to stream PubMed, to step Corpus: 001858
to stream PubMed, to step Curation: 001858

Links to Exploration step

pubmed:19629668

Le document en format XML

<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">Oral immunization of mice with recombinant Lactococcus lactis  expressing porcine transmissible gastroenteritis virus spike  glycoprotein.</title>
<author><name sortKey="Tang, Lijie" sort="Tang, Lijie" uniqKey="Tang L" first="Lijie" last="Tang">Lijie Tang</name>
<affiliation wicri:level="1"><nlm:affiliation>Life Science Department, Northeast Agricultural University, Harbin 150030, People's Republic of China.</nlm:affiliation>
<country xml:lang="fr">République populaire de Chine</country>
<wicri:regionArea>Life Science Department, Northeast Agricultural University, Harbin 150030</wicri:regionArea>
<wicri:noRegion>Harbin 150030</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Li, Yijing" sort="Li, Yijing" uniqKey="Li Y" first="Yijing" last="Li">Yijing Li</name>
</author>
</titleStmt>
<publicationStmt><idno type="wicri:source">PubMed</idno>
<date when="2009">2009</date>
<idno type="RBID">pubmed:19629668</idno>
<idno type="pmid">19629668</idno>
<idno type="doi">10.1007/s11262-009-0390-x</idno>
<idno type="wicri:Area/PubMed/Corpus">001858</idno>
<idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Corpus" wicri:corpus="PubMed">001858</idno>
<idno type="wicri:Area/PubMed/Curation">001858</idno>
<idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Curation">001858</idno>
<idno type="wicri:Area/PubMed/Checkpoint">001824</idno>
<idno type="wicri:explorRef" wicri:stream="Checkpoint" wicri:step="PubMed">001824</idno>
</publicationStmt>
<sourceDesc><biblStruct><analytic><title xml:lang="en">Oral immunization of mice with recombinant Lactococcus lactis  expressing porcine transmissible gastroenteritis virus spike  glycoprotein.</title>
<author><name sortKey="Tang, Lijie" sort="Tang, Lijie" uniqKey="Tang L" first="Lijie" last="Tang">Lijie Tang</name>
<affiliation wicri:level="1"><nlm:affiliation>Life Science Department, Northeast Agricultural University, Harbin 150030, People's Republic of China.</nlm:affiliation>
<country xml:lang="fr">République populaire de Chine</country>
<wicri:regionArea>Life Science Department, Northeast Agricultural University, Harbin 150030</wicri:regionArea>
<wicri:noRegion>Harbin 150030</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Li, Yijing" sort="Li, Yijing" uniqKey="Li Y" first="Yijing" last="Li">Yijing Li</name>
</author>
</analytic>
<series><title level="j">Virus genes</title>
<idno type="eISSN">1572-994X</idno>
<imprint><date when="2009" type="published">2009</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
</fileDesc>
<profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Administration, Oral</term>
<term>Animals</term>
<term>Antibodies, Neutralizing (immunology)</term>
<term>Antibodies, Viral (immunology)</term>
<term>Drug Carriers</term>
<term>Enzyme-Linked Immunosorbent Assay</term>
<term>Genetic Vectors</term>
<term>Intestinal Mucosa (immunology)</term>
<term>Lactococcus lactis (genetics)</term>
<term>Membrane Glycoproteins (genetics)</term>
<term>Membrane Glycoproteins (immunology)</term>
<term>Mice</term>
<term>Mice, Inbred BALB C</term>
<term>Neutralization Tests</term>
<term>Recombinant Proteins (genetics)</term>
<term>Recombinant Proteins (immunology)</term>
<term>Serum (immunology)</term>
<term>Spike Glycoprotein, Coronavirus</term>
<term>Transmissible gastroenteritis virus (genetics)</term>
<term>Transmissible gastroenteritis virus (immunology)</term>
<term>Vaccines, Synthetic (genetics)</term>
<term>Vaccines, Synthetic (immunology)</term>
<term>Viral Envelope Proteins (genetics)</term>
<term>Viral Envelope Proteins (immunology)</term>
<term>Viral Vaccines (administration & dosage)</term>
<term>Viral Vaccines (genetics)</term>
<term>Viral Vaccines (immunology)</term>
</keywords>
<keywords scheme="KwdFr" xml:lang="fr"><term>Administration par voie orale</term>
<term>Animaux</term>
<term>Anticorps antiviraux (immunologie)</term>
<term>Anticorps neutralisants (immunologie)</term>
<term>Glycoprotéine de spicule des coronavirus</term>
<term>Glycoprotéines membranaires (génétique)</term>
<term>Glycoprotéines membranaires (immunologie)</term>
<term>Lactococcus lactis (génétique)</term>
<term>Muqueuse intestinale (immunologie)</term>
<term>Protéines de l'enveloppe virale (génétique)</term>
<term>Protéines de l'enveloppe virale (immunologie)</term>
<term>Protéines recombinantes (génétique)</term>
<term>Protéines recombinantes (immunologie)</term>
<term>Souris</term>
<term>Souris de lignée BALB C</term>
<term>Sérum (immunologie)</term>
<term>Test ELISA</term>
<term>Tests de neutralisation</term>
<term>Vaccins antiviraux (administration et posologie)</term>
<term>Vaccins antiviraux (génétique)</term>
<term>Vaccins antiviraux (immunologie)</term>
<term>Vaccins synthétiques (génétique)</term>
<term>Vaccins synthétiques (immunologie)</term>
<term>Vecteurs de médicaments</term>
<term>Vecteurs génétiques</term>
<term>Virus de la gastroentérite transmissible (génétique)</term>
<term>Virus de la gastroentérite transmissible (immunologie)</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="administration & dosage" xml:lang="en"><term>Viral Vaccines</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="genetics" xml:lang="en"><term>Membrane Glycoproteins</term>
<term>Recombinant Proteins</term>
<term>Vaccines, Synthetic</term>
<term>Viral Envelope Proteins</term>
<term>Viral Vaccines</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="immunology" xml:lang="en"><term>Antibodies, Neutralizing</term>
<term>Antibodies, Viral</term>
<term>Membrane Glycoproteins</term>
<term>Recombinant Proteins</term>
<term>Vaccines, Synthetic</term>
<term>Viral Envelope Proteins</term>
<term>Viral Vaccines</term>
</keywords>
<keywords scheme="MESH" qualifier="administration et posologie" xml:lang="fr"><term>Vaccins antiviraux</term>
</keywords>
<keywords scheme="MESH" qualifier="genetics" xml:lang="en"><term>Lactococcus lactis</term>
<term>Transmissible gastroenteritis virus</term>
</keywords>
<keywords scheme="MESH" qualifier="génétique" xml:lang="fr"><term>Glycoprotéines membranaires</term>
<term>Lactococcus lactis</term>
<term>Protéines de l'enveloppe virale</term>
<term>Protéines recombinantes</term>
<term>Vaccins antiviraux</term>
<term>Vaccins synthétiques</term>
<term>Virus de la gastroentérite transmissible</term>
</keywords>
<keywords scheme="MESH" qualifier="immunologie" xml:lang="fr"><term>Anticorps antiviraux</term>
<term>Anticorps neutralisants</term>
<term>Glycoprotéines membranaires</term>
<term>Muqueuse intestinale</term>
<term>Protéines de l'enveloppe virale</term>
<term>Protéines recombinantes</term>
<term>Sérum</term>
<term>Vaccins antiviraux</term>
<term>Vaccins synthétiques</term>
<term>Virus de la gastroentérite transmissible</term>
</keywords>
<keywords scheme="MESH" qualifier="immunology" xml:lang="en"><term>Intestinal Mucosa</term>
<term>Serum</term>
<term>Transmissible gastroenteritis virus</term>
</keywords>
<keywords scheme="MESH" xml:lang="en"><term>Administration, Oral</term>
<term>Animals</term>
<term>Drug Carriers</term>
<term>Enzyme-Linked Immunosorbent Assay</term>
<term>Genetic Vectors</term>
<term>Mice</term>
<term>Mice, Inbred BALB C</term>
<term>Neutralization Tests</term>
<term>Spike Glycoprotein, Coronavirus</term>
</keywords>
<keywords scheme="MESH" xml:lang="fr"><term>Administration par voie orale</term>
<term>Animaux</term>
<term>Glycoprotéine de spicule des coronavirus</term>
<term>Souris</term>
<term>Souris de lignée BALB C</term>
<term>Test ELISA</term>
<term>Tests de neutralisation</term>
<term>Vecteurs de médicaments</term>
<term>Vecteurs génétiques</term>
</keywords>
</textClass>
</profileDesc>
</teiHeader>
<front><div type="abstract" xml:lang="en">Lactococcus lactis NZ9000 was selected as an antigen delivery vehicle for mucosal immunization against porcine transmissible gastroenteritis virus (TGEV) infection. An approximately 70 kDa fragment of the N-terminal globular domain of the spike (S) protein (SN protein) from the coronavirus TGEV was used as the transmissible gastroenteritis virus antigen model. Recombinant L. lactis, expressing the SN protein, was constructed with the pNZ8112 plasmid. Expression and localization of the transcribed SN protein from the recombinant LNZ9000- rTGEV-SN were detected via SDS-PAGE, Western blot, and immunofluorescence. BALB/c mice, orally immunized with LNZ9000-rTGEV-SN, produced local mucosal immune responses against TGEV. The induced antibodies demonstrated neutralizing effects on TGEV infection. These data indicated that the recombinant L. lactis could be a valuable tool in the development of future vaccines against TGEV.</div>
</front>
</TEI>
<pubmed><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">19629668</PMID>
<DateCompleted><Year>2011</Year>
<Month>06</Month>
<Day>08</Day>
</DateCompleted>
<DateRevised><Year>2020</Year>
<Month>04</Month>
<Day>15</Day>
</DateRevised>
<Article PubModel="Print"><Journal><ISSN IssnType="Electronic">1572-994X</ISSN>
<JournalIssue CitedMedium="Internet"><Volume>39</Volume>
<Issue>2</Issue>
<PubDate><Year>2009</Year>
<Month>Oct</Month>
</PubDate>
</JournalIssue>
<Title>Virus genes</Title>
<ISOAbbreviation>Virus Genes</ISOAbbreviation>
</Journal>
<ArticleTitle>Oral immunization of mice with recombinant Lactococcus lactis  expressing porcine transmissible gastroenteritis virus spike  glycoprotein.</ArticleTitle>
<Pagination><MedlinePgn>238-45</MedlinePgn>
</Pagination>
<ELocationID EIdType="doi" ValidYN="Y">10.1007/s11262-009-0390-x</ELocationID>
<Abstract><AbstractText>Lactococcus lactis NZ9000 was selected as an antigen delivery vehicle for mucosal immunization against porcine transmissible gastroenteritis virus (TGEV) infection. An approximately 70 kDa fragment of the N-terminal globular domain of the spike (S) protein (SN protein) from the coronavirus TGEV was used as the transmissible gastroenteritis virus antigen model. Recombinant L. lactis, expressing the SN protein, was constructed with the pNZ8112 plasmid. Expression and localization of the transcribed SN protein from the recombinant LNZ9000- rTGEV-SN were detected via SDS-PAGE, Western blot, and immunofluorescence. BALB/c mice, orally immunized with LNZ9000-rTGEV-SN, produced local mucosal immune responses against TGEV. The induced antibodies demonstrated neutralizing effects on TGEV infection. These data indicated that the recombinant L. lactis could be a valuable tool in the development of future vaccines against TGEV.</AbstractText>
</Abstract>
<AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Tang</LastName>
<ForeName>Lijie</ForeName>
<Initials>L</Initials>
<AffiliationInfo><Affiliation>Life Science Department, Northeast Agricultural University, Harbin 150030, People's Republic of China.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Li</LastName>
<ForeName>Yijing</ForeName>
<Initials>Y</Initials>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType>
<PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType>
</PublicationTypeList>
</Article>
<MedlineJournalInfo><Country>United States</Country>
<MedlineTA>Virus Genes</MedlineTA>
<NlmUniqueID>8803967</NlmUniqueID>
<ISSNLinking>0920-8569</ISSNLinking>
</MedlineJournalInfo>
<ChemicalList><Chemical><RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D057134">Antibodies, Neutralizing</NameOfSubstance>
</Chemical>
<Chemical><RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D000914">Antibodies, Viral</NameOfSubstance>
</Chemical>
<Chemical><RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D004337">Drug Carriers</NameOfSubstance>
</Chemical>
<Chemical><RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="C578553">MHV surface projection glycoprotein</NameOfSubstance>
</Chemical>
<Chemical><RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D008562">Membrane Glycoproteins</NameOfSubstance>
</Chemical>
<Chemical><RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D011994">Recombinant Proteins</NameOfSubstance>
</Chemical>
<Chemical><RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D064370">Spike Glycoprotein, Coronavirus</NameOfSubstance>
</Chemical>
<Chemical><RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D014614">Vaccines, Synthetic</NameOfSubstance>
</Chemical>
<Chemical><RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D014759">Viral Envelope Proteins</NameOfSubstance>
</Chemical>
<Chemical><RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D014765">Viral Vaccines</NameOfSubstance>
</Chemical>
<Chemical><RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="C578557">spike glycoprotein, SARS-CoV</NameOfSubstance>
</Chemical>
</ChemicalList>
<CitationSubset>IM</CitationSubset>
<MeshHeadingList><MeshHeading><DescriptorName UI="D000284" MajorTopicYN="N">Administration, Oral</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D057134" MajorTopicYN="N">Antibodies, Neutralizing</DescriptorName>
<QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D000914" MajorTopicYN="N">Antibodies, Viral</DescriptorName>
<QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D004337" MajorTopicYN="Y">Drug Carriers</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D004797" MajorTopicYN="N">Enzyme-Linked Immunosorbent Assay</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D005822" MajorTopicYN="Y">Genetic Vectors</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D007413" MajorTopicYN="N">Intestinal Mucosa</DescriptorName>
<QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D013294" MajorTopicYN="N">Lactococcus lactis</DescriptorName>
<QualifierName UI="Q000235" MajorTopicYN="Y">genetics</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D008562" MajorTopicYN="N">Membrane Glycoproteins</DescriptorName>
<QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName>
<QualifierName UI="Q000276" MajorTopicYN="Y">immunology</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D051379" MajorTopicYN="N">Mice</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D008807" MajorTopicYN="N">Mice, Inbred BALB C</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D009500" MajorTopicYN="N">Neutralization Tests</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D011994" MajorTopicYN="N">Recombinant Proteins</DescriptorName>
<QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName>
<QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D044967" MajorTopicYN="N">Serum</DescriptorName>
<QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D064370" MajorTopicYN="N">Spike Glycoprotein, Coronavirus</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D005760" MajorTopicYN="N">Transmissible gastroenteritis virus</DescriptorName>
<QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName>
<QualifierName UI="Q000276" MajorTopicYN="Y">immunology</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D014614" MajorTopicYN="N">Vaccines, Synthetic</DescriptorName>
<QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName>
<QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D014759" MajorTopicYN="N">Viral Envelope Proteins</DescriptorName>
<QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName>
<QualifierName UI="Q000276" MajorTopicYN="Y">immunology</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D014765" MajorTopicYN="N">Viral Vaccines</DescriptorName>
<QualifierName UI="Q000008" MajorTopicYN="Y">administration & dosage</QualifierName>
<QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName>
<QualifierName UI="Q000276" MajorTopicYN="Y">immunology</QualifierName>
</MeshHeading>
</MeshHeadingList>
</MedlineCitation>
<PubmedData><History><PubMedPubDate PubStatus="received"><Year>2009</Year>
<Month>03</Month>
<Day>10</Day>
</PubMedPubDate>
<PubMedPubDate PubStatus="accepted"><Year>2009</Year>
<Month>07</Month>
<Day>09</Day>
</PubMedPubDate>
<PubMedPubDate PubStatus="entrez"><Year>2009</Year>
<Month>7</Month>
<Day>25</Day>
<Hour>9</Hour>
<Minute>0</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="pubmed"><Year>2009</Year>
<Month>7</Month>
<Day>25</Day>
<Hour>9</Hour>
<Minute>0</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="medline"><Year>2011</Year>
<Month>6</Month>
<Day>9</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
</History>
<PublicationStatus>ppublish</PublicationStatus>
<ArticleIdList><ArticleId IdType="pubmed">19629668</ArticleId>
<ArticleId IdType="doi">10.1007/s11262-009-0390-x</ArticleId>
<ArticleId IdType="pmc">PMC7089002</ArticleId>
</ArticleIdList>
<ReferenceList><Reference><Citation>Infect Immun. 2003 Apr;71(4):1887-96</Citation>
<ArticleIdList><ArticleId IdType="pubmed">12654805</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Arch Virol. 1997;142(3):629-33</Citation>
<ArticleIdList><ArticleId IdType="pubmed">9349308</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>J Gen Virol. 1986 Jul;67 ( Pt 7):1405-18</Citation>
<ArticleIdList><ArticleId IdType="pubmed">2425049</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Virology. 1998 Sep 30;249(2):352-8</Citation>
<ArticleIdList><ArticleId IdType="pubmed">9791026</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Vaccine. 2002 Jul 26;20(23-24):2913-20</Citation>
<ArticleIdList><ArticleId IdType="pubmed">12126902</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Microbes Infect. 2006 Apr;8(4):1016-24</Citation>
<ArticleIdList><ArticleId IdType="pubmed">16549380</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>J Biotechnol. 1996 Jan 26;44(1-3):183-92</Citation>
<ArticleIdList><ArticleId IdType="pubmed">8717402</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Infect Immun. 2001 Mar;69(3):1547-53</Citation>
<ArticleIdList><ArticleId IdType="pubmed">11179325</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>J Dairy Sci. 2001 May;84(5):1001-10</Citation>
<ArticleIdList><ArticleId IdType="pubmed">11384025</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Clin Diagn Lab Immunol. 2001 May;8(3):545-51</Citation>
<ArticleIdList><ArticleId IdType="pubmed">11329455</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Ann N Y Acad Sci. 1983 Jun 30;409:177-93</Citation>
<ArticleIdList><ArticleId IdType="pubmed">6575708</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Appl Environ Microbiol. 2004 Feb;70(2):670-4</Citation>
<ArticleIdList><ArticleId IdType="pubmed">14766540</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>J Control Release. 2000 Mar 1;65(1-2):49-54</Citation>
<ArticleIdList><ArticleId IdType="pubmed">10699269</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>J Control Release. 2000 Jul 3;67(2-3):117-28</Citation>
<ArticleIdList><ArticleId IdType="pubmed">10825547</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Appl Environ Microbiol. 1983 Sep;46(3):549-52</Citation>
<ArticleIdList><ArticleId IdType="pubmed">6416164</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Adv Exp Med Biol. 1985;185:63-82</Citation>
<ArticleIdList><ArticleId IdType="pubmed">3000150</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Plasmid. 2007 Nov;58(3):275-83</Citation>
<ArticleIdList><ArticleId IdType="pubmed">17624430</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Plasmid. 1989 Jan;21(1):9-20</Citation>
<ArticleIdList><ArticleId IdType="pubmed">2727147</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Curr Issues Intest Microbiol. 2001 Mar;2(1):27-42</Citation>
<ArticleIdList><ArticleId IdType="pubmed">11709854</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>J Immunol Methods. 1992 Aug 30;153(1-2):263-4</Citation>
<ArticleIdList><ArticleId IdType="pubmed">1517598</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Curr Opin Immunol. 1994 Aug;6(4):572-83</Citation>
<ArticleIdList><ArticleId IdType="pubmed">7946045</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Appl Environ Microbiol. 1989 Dec;55(12):3119-23</Citation>
<ArticleIdList><ArticleId IdType="pubmed">16348073</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>J Virol. 1986 Oct;60(1):131-9</Citation>
<ArticleIdList><ArticleId IdType="pubmed">2427744</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>J Infect Dis. 2005 Oct 15;192(8):1441-9</Citation>
<ArticleIdList><ArticleId IdType="pubmed">16170763</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Biotechnol Bioeng. 2007 Apr 15;96(6):1127-38</Citation>
<ArticleIdList><ArticleId IdType="pubmed">17117427</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>J Immunol Methods. 1990 Oct 4;133(1):87-97</Citation>
<ArticleIdList><ArticleId IdType="pubmed">2212694</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Vaccine. 2005 Feb 3;23(11):1335-42</Citation>
<ArticleIdList><ArticleId IdType="pubmed">15661381</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Adv Virus Res. 2006;66:193-292</Citation>
<ArticleIdList><ArticleId IdType="pubmed">16877062</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Appl Environ Microbiol. 1999 Jan;65(1):351-4</Citation>
<ArticleIdList><ArticleId IdType="pubmed">9872808</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
</PubmedData>
</pubmed>
<affiliations><list><country><li>République populaire de Chine</li>
</country>
</list>
<tree><noCountry><name sortKey="Li, Yijing" sort="Li, Yijing" uniqKey="Li Y" first="Yijing" last="Li">Yijing Li</name>
</noCountry>
<country name="République populaire de Chine"><noRegion><name sortKey="Tang, Lijie" sort="Tang, Lijie" uniqKey="Tang L" first="Lijie" last="Tang">Lijie Tang</name>
</noRegion>
</country>
</tree>
</affiliations>
</record>

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Sante/explor/SrasV1/Data/PubMed/Checkpoint

HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 001824 | SxmlIndent | more

HfdSelect -h $EXPLOR_AREA/Data/PubMed/Checkpoint/biblio.hfd -nk 001824 | SxmlIndent | more

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Sante
   |area=    SrasV1
   |flux=    PubMed
   |étape=   Checkpoint
   |type=    RBID
   |clé=     pubmed:19629668
   |texte=   Oral immunization of mice with recombinant Lactococcus lactis  expressing porcine transmissible gastroenteritis virus spike  glycoprotein.
}}

Pour générer des pages wiki

HfdIndexSelect -h $EXPLOR_AREA/Data/PubMed/Checkpoint/RBID.i   -Sk "pubmed:19629668" \
       | HfdSelect -Kh $EXPLOR_AREA/Data/PubMed/Checkpoint/biblio.hfd   \
       | NlmPubMed2Wicri -a SrasV1

This area was generated with Dilib version V0.6.33.
Data generation: Tue Apr 28 14:49:16 2020. Site generation: Sat Mar 27 22:06:49 2021

	Serveur d'exploration SRAS
	Attention, ce site est en cours de développement ! Attention, site généré par des moyens informatiques à partir de corpus bruts. Les informations ne sont donc pas validées.

Serveur d'exploration SRAS

Oral immunization of mice with recombinant Lactococcus lactis expressing porcine transmissible gastroenteritis virus spike glycoprotein.

Oral immunization of mice with recombinant Lactococcus lactis expressing porcine transmissible gastroenteritis virus spike glycoprotein.

Source :

Descripteurs français

English descriptors

Abstract

Links toward previous steps (curation, corpus...)

Links to Exploration step

Le document en format XML

Pour manipuler ce document sous Unix (Dilib)

Pour mettre un lien sur cette page dans le réseau Wicri

Pour générer des pages wiki